hydroxychloroquine

Oklahoma is attempting to return $2 million worth of hydroxychloroquine

The World Health Organization released the findings of their coronavirus therapeutics study on Friday, which studied the impact of drugs like remdesivir and hydroxychloroquine on treating hospitalized coronavirus patients.

Researchers at the University of Oxford in the U.K. have concluded that hydroxychloroquine does nothing to prevent COVID-19-related deaths, NBC News reports.

The World Health Organization has warned that there might never be a “silver bullet” to protect against the coronavirus. Dr. Bob Lahita, a professor of medicine at New York Medical College, joined LX News to explain why vaccine progress is making him more hopeful.

President Donald Trump is making grandiose claims about slashing drug prices and the efficacy of a treatment for COVID-19 that don’t hold up to reality.

With more 150,000 deaths from COVID-19 and 4 million confirmed cases in the United States, President Donald Trump continues to tout an unproven treatment for the coronavirus. While some treatments have been shown to improve survival or lessen the severity of the disease, leading infectious disease experts, doctors and virologists say it’s time to stop promoting one that hasn’t: hydroxychloroquine.

Rep. James Sensenbrenner, R-WI, criticized Facebook’s decision to remove a viral video of doctors claiming hydroxychloroquine cures COVID-19. CEO Mark Zuckerberg defended the decision saying that “some of the data suggests it might be harmful to people, we think we should take that down. That could cause imminent risk of harm.”

At a press conference on Tuesday, President Donald Trump doubled down on his support of anti-malaria drug hydroxychloroquine after a viral video was removed from social platforms on Monday after it falsely claimed the drug is a successful treatment of the coronavirus.

Brazilian President Jair Bolsonaro says he is confident that he will swiftly recover from the new coronavirus thanks to treatment with hydroxychloroquine, the anti-malaria drug that has not been proven effective against COVID-19.

Brazil’s president Jair Bolsonaro announced on Tuesday that he has tested positive for the coronavirus after months of downplaying the pandemic.

Peter Pitts, the former FDA Associate Commissioner, said industry, academia and government are working together to make an effective coronavirus vaccine available by early 2021. But the rollout is expected to be complicated, with more than one vaccine likely available and questions about which groups should be prioritized to get the vaccine first.

In a meeting at the White House, Health and Human Services Secretary Alex Azar left the misleading impression that the Food and Drug Administration’s decision to revoke its emergency use authorization of hydroxychloroquine and chloroquine for COVID-19 “removes a potential barrier” and makes it easier to access the drugs. The FDA’s action does the opposite. Following Azar’s lead, President...

The World Health Organization has halted research on whether hydroxychloroquine could be an effective treatment for COVID-19. Multiple studies have shown that the drug, an anti-malarial medicine also used to treat lupus and rheumatoid arthritis, has no impact on the coronavirus. The WHO said in a statement Wednesday that recent findings “showed that hydroxychloroquine does not result in the reduction...

The U.S. Food and Drug Administration on Monday rescinded its emergency use approval for hydroxychloroquine and chloroquine in treating COVID-19.

Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday — have suggested it does little to treat infection while exposing users to dangerous side effects. Not all researchers have given up on the drug, however, and recent developments show it...

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report

The White House medical team kept a close eye on President Donald Trump’s heart rhythms, including at least one electrocardiogram, when he took a two-week course of a malaria drug to try to prevent the coronavirus

A new study out of the University of Minnesota suggests that anti-malarial drug hydroxychloroquine has no effect on preventing patients from contracting the novel coronavirus.

Researchers say that a malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in health workers and others closely exposed to people with the disease

France, Italy and Belgium announced on Wednesday they would ban the use of hydroxychloroquine to treat coronavirus patients after recent studies revealed serious safety issues with the anti-malaria drug.